Cargando…

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma

The aim of the present study was to compare overall survival between stage IVA or stage IVB hepatocellular carcinoma (HCC) patients who received transcatheter arterial chemoembolization (TACE) and those who were treated with sorafenib. This retrospective comparative study included 55 patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales:	NISHIKAWA, HIROKI, OSAKI, YUKIO, IGUCHI, ERIKO, TAKEDA, HARUHIKO, NAKAJIMA, JUN, MATSUDA, FUMIHIRO, SAKAMOTO, AZUSA, HENMI, SHINICHIRO, HATAMARU, KEIICHI, SAITO, SUMIO, NASU, AKIHIRO, KITA, RYUICHI, KIMURA, TORU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503544/ https://www.ncbi.nlm.nih.gov/pubmed/23181103 http://dx.doi.org/10.3892/etm.2012.611

Ejemplares similares

Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2011)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases
por: Takeda, Haruhiko, et al.
Publicado: (2012)

Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin
por: Nishikawa, Hiroki, et al.
Publicado: (2010)

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
por: Takeda, Haruhiko, et al.
Publicado: (2019)

Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
por: Takano, Michitoshi, et al.
Publicado: (2016)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter
por: Yamashina, Takeshi, et al.
Publicado: (2018)

Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
por: Huang, Yao-Kuang, et al.
Publicado: (2017)

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis
por: Yamashina, Takeshi, et al.
Publicado: (2017)

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Transcatheter Arterial Chemoembolization and Chemotherapy plus Sorafenib in a Large Hepatocellular Carcinoma with Arterioportal Shunt
por: Chen, Jun, et al.
Publicado: (2014)

Treatment for Hepatocellular Carcinoma in Elderly Patients: A Literature Review
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib
por: Fu, Sirui, et al.
Publicado: (2016)

Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion
por: Yang, Dan, et al.
Publicado: (2023)

Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion
por: Zhao, Yuting, et al.
Publicado: (2019)

The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma
por: Su, Dongna
Publicado: (2021)

Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis
por: Ohki, Takamasa, et al.
Publicado: (2015)

Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials
por: Li, Jun, et al.
Publicado: (2017)

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
por: He, Kun, et al.
Publicado: (2022)

Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib
por: Sakai, Kazuko, et al.
Publicado: (2015)

The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Comparison of Clinical Characteristics and Survival after Surgery in Patients with Non-B and Non-C Hepatocellular Carcinoma and Hepatitis Virus-Related Hepatocellular Carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma
por: Arizumi, Tadaaki, et al.
Publicado: (2014)

Erratum to: Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis
por: Ohki, Takamasa, et al.
Publicado: (2016)

Efficacy of transcatheter arterial chemoembolization combined with sorafenib in inhibiting tumor angiogenesis in a rabbit VX2 liver cancer model
por: Li, WeiZhi, et al.
Publicado: (2020)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020)

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy
por: NISHIKAWA, HIROKI, et al.
Publicado: (2013)

Cure of Hepatoblastoma Through Transcatheter Arterial Chemoembolization
por: Yang, Tianyou, et al.
Publicado: (2017)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b7gm3upgf8v4anun715g24u2m2